Rapid rule out of myocardial infarction with the use of copeptin as a biomarker for cardiac injury

Internal Medicine Journal

Volumn 44, Issue 9, 2014, Pages 921-924

  Jayasinghe, Rohan ^a,b   Narasimhan, S ^c,d   Tran, T H ^e   Paskaranandavadivel, A ^f  

^a GOLD COAST UNIVERSITY HOSPITAL   (Australia)

^b GRIFFITH UNIVERSITY   (Australia)

^c Manning Rural Referral Hospital   (Australia)

^d UNIVERSITY OF NEW ENGLAND   (Australia)

^e ANZAC Research Institute   (Australia)

^f BOND UNIVERSITY   (Australia)

Author keywords

Acute coronary syndrome; Arginine vasopressin precursor; Copeptin; Emergency department; Myocardial infarction; Troponin

Indexed keywords

ARGIPRESSIN; BIOLOGICAL MARKER; COPEPTIN; TROPONIN T; GLYCOPEPTIDE; TROPONIN;

ACUTE HEART INFARCTION; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL PRACTICE; ELECTROCARDIOGRAPHY; HEART INJURY; HEART MUSCLE ISCHEMIA; HEMOSTASIS; HUMAN; HYPOTHALAMUS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IN VITRO STUDY; INTENTION TO TREAT ANALYSIS; INTERMEDIATE RISK PATIENT; MULTICENTER STUDY (TOPIC); NEUROHYPOPHYSIS; OSMOREGULATION; PATIENT CARE; PRACTICE GUIDELINE; PREDICTIVE VALUE; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; ACUTE CORONARY SYNDROME; ALGORITHM; AUSTRALIA; BLOOD; EMERGENCY HEALTH SERVICE; MYOCARDIAL INFARCTION; THORAX PAIN;

ACUTE CORONARY SYNDROME; ALGORITHMS; AUSTRALIA; BIOLOGICAL MARKERS; CHEST PAIN; EMERGENCY SERVICE, HOSPITAL; GLYCOPEPTIDES; HUMANS; MYOCARDIAL INFARCTION; PREDICTIVE VALUE OF TESTS; TROPONIN;

EID: 84912136449     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/imj.12526     Document Type: Article

References (17)

1. Parsonage WA, Cullen L, Younger JF. The approach to patients with possible cardiac chest pain. Med J Aust 2013; 199: 30-4.
2. Geelhoed G, de Klerk N. Emergency department overcrowding, mortality and the 4-hour rule in Western Australia. Med J Aust 2012; 196: 122-6.
3. Maumill L, Zic M, Esson AA, Geelhoed GC, Borland MM, Johnson C et al. The National Emergency Access Target (NEAT): can quality go with timeliness? Med J Aust 2013; 198: 153-7.
4. Jneid H, Anderson JL, Wright RS, Adams CD, Bridges CR, Casey DE et al. 2012 ACCF/AHA focused update of the guideline for the management of patients with unstable angina/non-ST-elevation myocardial infarction (updating the 2007 guideline and replacing the 2011 focused update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2012; 60: 645-81.
5. Hamm CW, Bassand JP, Agewall S, Bax JL, Boersma E, Bueno H et al. ESC Committee for practice guidelines. ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J 2011; 32: 2999-3054.
6. Chew DP, Aroney CN, Aylward PE, Kelly AM, White HD, Tideman PA et al. 2011 addendum to the National Heart Foundation of Australia/Cardiac Society of Australia and New Zealand guidelines for the management of acute coronary syndromes (ACS) 2006. Heart Lung Circ 2011; 20: 487-502.
7. Eggers KM, Oldgren J, Nordenskjold A, Lindahl B. Diagnostic value of serial measurement of cardiac markers in patients with chest pain: limited value of adding myoglobin to troponin I for exclusion of myocardial infarction. Am Heart J 2004; 148: 574-81.
8. Maisel A, Mueller C, Neath SX, Christenson RH, Morgnthaler NG, McCord J et al. Copeptin helps in the early detection of patients with acute myocardial infarction-primary results of the CHOPIN trial (copeptin helps in the early detection of patients with acute myocardial INfarction). J Am Coll Cardiol 2013; 62: 150-60.
9. Singh Ranger G. The physiology and emerging roles of antidiuretic hormone. Int J Clin Pract 2002; 56: 777-82.
10. Itoi K, Jiang YQ, Iwasaki Y, Watson SJ. Regulatory mechanisms of corticotropin-releasing hormone and vasopressin gene expression in the hypothalamus. J Neuroendocrinol 2004; 16: 348-55.
11. Robertson GL, Mahr EA, Athar S, Sinha T. Development and clinical application of a new method for the radioimmunoassay of arginine vasopressin in human plasma. J Clin Invest 1973; 52: 2340-52.
12. Preibisz JJ, Sealey JE, Laragh JH, Cody RJ, Weksler BB. Plasma and platelet vasopressin in essential hypertension and congestive heart failure. Hypertension 1983; 5: I129-38.
13. Khan SQ, Dhillon O, O'Brien RJ, Struck J, Quinn PA, Morgenthaler NG et al. C-terminal provasopressin (copeptin) as a novel and prognostic marker in acute myocardial infarction: Leicester Acute Myocardial Infarction Peptide (LAMP) study. Circulation 2007; 115: 2103-10.
14. Reichlin T, Hochholzer W, Stelzig C, Laule K, Freidank H, Morgenthaler NG et al. Incremental value of copeptin for rapid rule out of acute myocardial infarction. J Am Coll Cardiol 2009; 54: 60-8.
15. Keller T, Tzikas S, Zeller T, Czyz E, Lillpop L, Ojeda FM et al. Copeptin improves early diagnosis of acute myocardial infarction. J Am Coll Cardiol 2010; 55: 2096-106.
16. Parsonage WA, Greenslade JH, Hammett CJ, Lamanna A, Tate JR, Ungerer JP et al. Validation of an accelerated high-sensitivity troponin T assay protocol in an Australian cohort with chest pain. Med J Aust 2014; 200: 161-5.
17. Moeckel M, Lindahl B. BIC8: instant early rule out using cardiac troponin and copeptin in low to intermediate risk patients with suspected ACS: a prospective, randomized multicenter study. 2013. Session 709: European Society of Cardiology (ESC) 2013 Congress.